Professor, Medicine, University of Miami School of Medicine
Infectious Disease
Dr. Rafael E. Campo, MD
|
|
Give Review
Dr. Rafael E. Campo is an expert in the field of Infectious Disease. Rafael Campo is a published doctor and has 42 publications published. The lastest was: 'Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.' Rafael Campo is registered with Medicare and accepts Medicare payments.
Publications
- Predictors of Short-Term Diabetes Remission After Laparoscopic Roux-en-Y Gastric Bypass.
- SWIFT: Prospective 48 Week Study to Evaluate Efficacy and Safety of Switching to Emtricitibine/Tenofovir from Lamivudine/Abacavir in Virologically Suppressed HIV-1 Inf...
- Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-week Results from the REALMRK Study.
- Infection control in field hospitals after a natural disaster: lessons learned after the 2010 earthquake in Haiti.
- An academic center's delivery of care after the Haitian earthquake.
- Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine.
- Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis.
- Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients.
- Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunolo...
- Antiretroviral treatment considerations in Latino patients.
- Differences in presentation and outcome of invasive pneumococcal disease among patients with and without HIV infection in the pre-HAART era.
- Impact of resistance to antiretroviral therapy in the minority community.
- HIV-related pneumonia care in older patients hospitalized in the early HAART era.
- Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance.
- Differences in the frequency of resistance to antiretroviral drug classes among human immunodeficiency virus type 1 clinical isolates.
- Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer.
- Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis.
- Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test.
- Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain.
- Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
- Just the facts.
- Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.
- Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study.
- M proteins of group G streptococci: mechanisms of resistance to phagocytosis.
- Limited usefulness of a seven-day twice-a-day quadruple therapy.
- Identification of factors that influence tolerance of upper gastrointestinal endoscopy.
- Subcutaneous nodules as a dermatologic manifestation of bacteremia due to Pseudomonas aeruginosa.
- Fulminant hepatitis from herpes simplex virus type 2 in an immunocompetent adult.
- Questions for an epidemic.
- Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: M...
- Mycobacterium kansasii disease in patients infected with human immunodeficiency virus.
- HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era.
- Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk fo...
- Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological ...
- The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study.
- Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).
- Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).
- Efficacy of indinavir-ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures.
- Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: is it inevitable?
- Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients.
- Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Jackson Memorial Hospital - Jackson Health System -
Mount Sinai Medical Center of Florida -
Esc Auto De Cien Med De Centro America
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1902860869 | |
| NPPES Provider LastName | CAMPO | |
| NPPES Provider FirstName | RAFAEL | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 539.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 4.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902860869 |
| Last Name Of The Provider | CAMPO |
| First Name Of The Provider | RAFAEL |
| View All |
Similar Doctors
|
|
Dr. Stacey E. Baker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan A. Jacobson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon M. Dickinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan L. Bisno, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jorge M. Diego, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard B. Baker, MD |
|
Dr. Efrain Garcia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele I. Morris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gilberto Rodriguez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia M. Leon, MD |
|
|
Dr. Allan E. Rodriguez, MD
This Doctor is OpenDoctor Recommended.
|